Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of DKK 14.24 billion. The enterprise value is 17.28 billion.

Market Cap	14.24B
Enterprise Value	17.28B

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Embla Medical has 426.22 million shares outstanding. The number of shares has decreased by -0.29% in one year.

Current Share Class	426.22M
Shares Outstanding	426.22M
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	+4.94%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	73.78%
Float	160.64M

Valuation Ratios

The trailing PE ratio is 28.60 and the forward PE ratio is 25.78. Embla Medical's PEG ratio is 1.19.

PE Ratio	28.60
Forward PE	25.78
PS Ratio	2.40
PB Ratio	2.57
P/TBV Ratio	n/a
P/FCF Ratio	19.35
P/OCF Ratio	16.39
PEG Ratio	1.19

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.54, with an EV/FCF ratio of 23.48.

EV / Earnings	34.68
EV / Sales	2.92
EV / EBITDA	14.54
EV / EBIT	20.24
EV / FCF	23.48

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.66.

Current Ratio	1.74
Quick Ratio	0.90
Debt / Equity	0.66
Debt / EBITDA	3.13
Debt / FCF	4.96
Interest Coverage	5.36

Financial Efficiency

Return on equity (ROE) is 9.46% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	9.46%
Return on Assets (ROA)	4.80%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.94%
Revenue Per Employee	1.48M
Profits Per Employee	124,537
Employee Count	4,061
Asset Turnover	0.55
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.43% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+20.43%
50-Day Moving Average	29.37
200-Day Moving Average	32.35
Relative Strength Index (RSI)	56.42
Average Volume (20 Days)	64,428

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of DKK 5.92 billion and earned 498.15 million in profits. Earnings per share was 1.17.

Revenue	5.92B
Gross Profit	3.74B
Operating Income	831.19M
Pretax Income	657.32M
Net Income	498.15M
EBITDA	986.91M
EBIT	831.19M
Earnings Per Share (EPS)	1.17

Full Income Statement

Balance Sheet

The company has 633.38 million in cash and 3.65 billion in debt, giving a net cash position of -3.01 billion or -7.07 per share.

Cash & Cash Equivalents	633.38M
Total Debt	3.65B
Net Cash	-3.01B
Net Cash Per Share	-7.07
Equity (Book Value)	5.53B
Book Value Per Share	12.91
Working Capital	1.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 868.51 million and capital expenditures -132.78 million, giving a free cash flow of 735.74 million.

Operating Cash Flow	868.51M
Capital Expenditures	-132.78M
Free Cash Flow	735.74M
FCF Per Share	1.73

Full Cash Flow Statement

Margins

Gross margin is 63.19%, with operating and profit margins of 14.04% and 8.41%.

Gross Margin	63.19%
Operating Margin	14.04%
Pretax Margin	11.10%
Profit Margin	8.41%
EBITDA Margin	16.67%
EBIT Margin	14.04%
FCF Margin	12.43%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.29%
Shareholder Yield	n/a
Earnings Yield	3.50%
FCF Yield	5.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 3.09.

Altman Z-Score	3.09
Piotroski F-Score	n/a